Myosana Therapeutics, a biotech company based in Seattle, WA, closed a new $5 million financing round to support further development of their non-viral gene therapy technology for the treatment of [...]
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you are agreeing to accept our use of cookies. For more information about cookies please visit our Privacy Policy page.I Agree